Title
Gaucher disease and SARS-CoV-2 infection: Emerging management challenges
UMMS Affiliation
Lysosomal Disorders Treatment and Research Program; Department of Psychiatry; Department of Neurology
Publication Date
2020-05-11
Document Type
Article
Disciplines
Congenital, Hereditary, and Neonatal Diseases and Abnormalities | Health Services Administration | Infectious Disease | Nervous System Diseases | Nutritional and Metabolic Diseases | Virus Diseases
Abstract
A group of investigators and physician experts in Gaucher disease along with patient advocacy organizations in the United States convened to propose management guidelines and to identify research questions during these challenging times. The overarching goal of this collaborative group is to delineate the emerging impact of the SARS-CoV-2 pandemic on patients with Gaucher disease and to develop optimal clinical practice guidelines for managing the infection.
Keywords
SARS-CoV-2, COVID-19, pandemic, Gaucher disease
DOI of Published Version
10.1016/j.ymgme.2020.05.002
Source
Mistry P, Balwani M, Barbouth D, Burrow TA, Ginns EI, Goker-Alpan O, Grabowski GA, Kartha RV, Kishnani PS, Lau H, Lee CU, Lopez G, Maegawa G, Packman S, Prada C, Rosenbloom B, Lal TR, Schiffmann R, Weinreb N, Sidransky E. Gaucher disease and SARS-CoV-2 infection: Emerging management challenges. Mol Genet Metab. 2020 Jul;130(3):164-169. doi: 10.1016/j.ymgme.2020.05.002. Epub 2020 May 11. PMID: 32471800; PMCID: PMC7211677. Link to article on publisher's site
Journal/Book/Conference Title
Molecular genetics and metabolism
Related Resources
PubMed ID
32471800
Repository Citation
Mistry P, Ginns EI, Sidransky E. (2020). Gaucher disease and SARS-CoV-2 infection: Emerging management challenges. COVID-19 Publications by UMMS Authors. https://doi.org/10.1016/j.ymgme.2020.05.002. Retrieved from https://escholarship.umassmed.edu/covid19/44
Comments
Full author list omitted for brevity. For the full list of authors, see article.